April 2026
Core topics in this month’s edition include:
- Trividia Health – Recall of True Metrix® Self-Monitoring Blood glucose meters
- Saphnelo® (anifrolumab-fnia) – New formulation approval
- Breztri Aerosphere® (budesonide/glycopyrrolate/formoterol fumarate) – New indication, new strength